Table 1.
Type of RD | RD or RD group | ICD10 | ORPHA code | n | Diagnostic delay (%) | ||
---|---|---|---|---|---|---|---|
Total | Men–Women | Total (%) | Men–Women (%) | ||||
Diseases of the nervous system | Total | G00–G99 | 822 | 375–447 | 64.2 | 63.2–65.1 | |
Tarlov cyst | G58.9 | 65, 250 | 128 | 14–114 | 57.8 | 64.3–57.0 | |
Muscular dystrophies | G71.0 | 98, 473* | 90 | 52–38 | 67.8 | 59.6–78.9 | |
Hereditary ataxias | G11 | 183, 518* | 74 | 40–34 | 63.5 | 67.5–58.8 | |
Post-poliomyelitis syndrome | G14.0 | 2942 | 56 | 30–26 | 83.9 | 80.0–88.5 | |
Hereditary spastic paraplegia | G11.4 | 685* | 53 | 33–20 | 88.7 | 84.8–95.0 | |
Amyotrophic lateral sclerosis | G12.2 | 803 | 36 | 22–14 | 52.8 | 59.1–42.9 | |
Myasthenia gravis | G70.0 | 589 | 35 | 15–20 | 34.3 | 20.0–45.0 | |
Congenital malformations, deformations and chromosomal abnormalities | Total | Q00–Q99 | 700 | 308–392 | 48.4 | 45.8–50.5 | |
Arnold-Chiari malformation | Q07.0 | 1136, 268, 882 | 60 | 19–41 | 65.0 | 52.6–70.7 | |
Epidermolysis bullosa | Q81 | 304* | 38 | 20–18 | 44.7 | 40.0–50.0 | |
Diseases of the eye and adnexa | Total | H00–H59 | 668 | 349–319 | 62.9 | 57.6–68.7 | |
Retinitis pigmentosa | H35.5 | 791 | 384 | 185–199 | 65.1 | 61.1–68.8 | |
Stargardt disease | H35.5 | 827 | 72 | 35–37 | 56.9 | 48.6–64.9 | |
Usher syndrome | H35.5 | 886 | 55 | 32–23 | 76.4 | 71.9–82.6 | |
Cone-rod dystrophy | H35.5 | 1872 | 30 | 16–14 | 70.0 | 68.8–71.4 | |
Endocrine, nutritional and metabolic diseases | Total | E00–E90 | 267 | 131–136 | 55.4 | 48.9–61.8 | |
Diseases of the musculoskeletal system and connective tissue | Total | M00–M99 | 245 | 76–169 | 53.1 | 42.1–58.0 | |
Systemic sclerosis | M34 | 801* | 48 | 10–38 | 56.3 | 70.0–52.6 | |
Behçet’s disease | M35.2 | 117 | 31 | 9–22 | 71.0 | 55.6–77.3 | |
Sjögren-Larsson syndrome | M35.0 | 816 | 30 | 3–27 | 73.3 | 33.3–77.8 | |
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | Total | D50–D89 | 235 | 96–139 | 44.7 | 41.7–46.8 | |
Hereditary angioedema | D84.1 | 91, 378* | 108 | 40–68 | 55.6 | 47.5–60.3 | |
Sarcoidosis | D86 | 797 | 50 | 25–25 | 26.0 | 28.0–24.0 | |
Diseases of the circulatory system | Total | I00–I99 | 82 | 10–72 | 51.2 | 30.0–54.2 | |
Lymphangioleiomyomatosis | I89.8 | 538 | 46 | **− 46 | 56.5 | **− 56.5 | |
Mental and behavioural disorders | Total | F00–F99 | 77 | 38–39 | 78.0 | 76.0–79.0 | |
Neoplasms | Total | C00–D48 | 65 | 27–38 | 35.0 | 37.0–34.0 | |
Diseases of the genitourinary system | Total | N00–N99 | 43 | 5–38 | 67.0 | 60.0–68.0 | |
Diseases of the skin and subcutaneous tissue | Total | L00–L99 | 30 | 9–21 | 53.0 | 67.0–48.0 | |
Total | 3304 | 1454-1850 | 56.4 | 53.4-58.8 |
*Group of disorders
**RDs that mainly affect women